Relief Cardiovascular has announced positive 90-day results from a study of its smart heart implant technology.

MARKED elevations of serum citrate have been reported to occur in man during multiple rapid transfusions of citrated blood. 1–3 The possibility of harmful effects is well recognized but often ...

In another hopeful sign for heart failure patients with preserved EF, pulmonary artery pressure monitoring with the CardioMEMS device (Abbott) seemed equally effective in reducing the risk of ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology for a minimally invasive, extravascular platform to provide hemodynamic support for ...

Fifth Eye, a Michigan-based real-time clinical analytics company, announced today that the Food and Drug Administration has granted De Novo classification for its Analytic for Hemodynamic Instability ...

THE question of how well the compensated human heart with a fixed rate in the physiologic range is capable of adapting to the demands for increased cardiac output has very practical implications for ...

Pacing Clin Electrophysiol. 2005;28(6):573-584. All the pilot-IHM systems described above required radio-frequency devices (programmers) to adjust data acquisition and storage formats of the various ...

Relief Cardiovascular, Inc., a private medical device company developing intelligent device-based therapy solutions for heart failure (HF) congestion, today announced positive 90-day results from the ...